NCT04543357View on ClinicalTrials.gov

A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

TerminatedOBSERVATIONAL

Enrollment

8

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

February 27, 2024

Study Completion Date

February 27, 2024

Conditions

Household Contacts

Interventions

OTHER

Blood Draw

Blood Samples for NAb and ADA to AAV9

Trial Locations (1)

21205

Kennedy Krieger Institute, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY